BIO-TECHNE Corp — Director's Dealing 2017

Feb 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2017-02-10

Reporting Person: LUCAS ROGER C (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-10	Common Stock	S	100.00	$102.60	Disposed	3729.00	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$101.19	2026-10-26	Common Stock (3985.00)	3985.00	Direct
Stock Option (right to buy)	$91.78	2024-10-30	Common Stock (4000.00)	4000.00	Direct
Stock Option (right to buy)	$87.39	2023-10-30	Common Stock (4000.00)	4000.00	Direct
Stock Option (right to buy)	$87.34	2025-10-28	Common Stock (4260.00)	4260.00	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016.

F2: The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders.